肝脏 ›› 2025, Vol. 30 ›› Issue (8): 1039-1045.

• 病毒性肝炎 • 上一篇    下一篇

急性戊型肝炎临床特征及进展为肝衰竭的危险因素分析

朱碧莲, 唐映梅, 包维民, 李秦念   

  1. 650000 云南昆明 昆明医科大学第二附属医院(朱碧莲,唐映梅,李秦念);650000 云南昆明 云南省第一人民医院(包维民)
  • 收稿日期:2024-08-29 发布日期:2025-09-19
  • 通讯作者: 唐映梅,Email:tangyingmei-med@kmmu.edu.cn
  • 基金资助:
    国家自然科学基金(82360108);中联肝健康促进中心(CLH2023-F-HEV-08);云南省陈洁专家工作站(202305AF150065);云南省医学领军人才(L-2019013);云南省万人计划-名医专项(YNWR-MY-2018-028)

An analysis on the clinical characteristics and risk factors for the progression of liver failure in acute hepatitis E patients

ZHU Bi-lian1, TANG Ying-mei1, BAO Wei-min2, LI Qin-nian1   

  1. 1. The Second Affiliated Hospital of Kunming Medical University, Kunming 650000, China;
    2. Yunnan First People′s Hospital of Yunnan Province, Kunming 650000, China
  • Received:2024-08-29 Published:2025-09-19
  • Contact: TANG Ying-mei,Email:tangyingmei-med@kummu.edu.cn

摘要: 目的 探究急性戊型肝炎进展为肝衰竭的危险因素。 方法 回顾性分析109例急性戊型肝炎患者的临床资料,根据患者年龄分为老年组和非老年组;按病因分为急性戊型肝炎组和急性戊型肝炎合并其他肝病组;根据是否进展为肝衰竭,分为肝衰竭组和非肝衰竭组;比较各组临床特点、实验室指标及治疗转归情况。 结果 分组情况为老年组37例,非老年组72例;戊型肝炎合并其他肝病组23例,戊型肝炎组86例;肝衰竭组23例,非肝衰竭组86例。女性33例,男性76例;35例治愈,61例好转,13例无效。老年组AST峰值、ALP峰值、TBil峰值、INR峰值、黄疸发生率、腹腔积液及肝性脑病并发症发生率、肝衰竭发生率、住院时间、住院费用均高于非老年组(P<0.05);Alb谷值、TC、HDL-C、治愈率低于非老年组(P<0.05),两组的性别、其余症状及并发症发生率、好转率、无效率比较差异无统计学意义(P>0.05)。合并其他肝病组TBil峰值、PT峰值、INR峰值、腹胀和乏力症状发生率、腹腔积液和肝性脑病并发症发生率、肝衰竭发生率均高于戊型肝炎组(P<0.05);Alb谷值、LDL-C低于戊型肝炎组(P<0.05);两组的性别、年龄、住院时间、住院费用、治愈率、好转率比较差异无统计学意义(P<0.05)。肝衰竭组ALT峰值、AST峰值、TBil峰值、PT峰值、APTT峰值、INR峰值、GLO、TG,黄疸、腹胀、乏力、纳差、皮肤瘙痒及尿色加深症状发生率,低蛋白血症、腹腔积液和肝性脑病并发症发生率、住院时间、住院费用、好转率均高于非肝衰竭组(P<0.05);Alb谷值、TC、HDL-C、治愈率低于非肝衰竭组(P<0.05),两组的性别、无效率、ALP峰值、γ-GGT峰值、Cr峰值、Ur峰值、LDL-C比较差异无统计学意义(P>0.05)。二元logistic回归分析,发现INR峰值、TBil峰值是戊型肝炎患者进展为肝衰竭的独立危险因素(P<0.05)。 结论 老年、戊型肝炎合并其他肝病患者病情重,易出现腹腔积液且肝性脑病并发症、肝衰竭发生率高,INR、TBil是戊型肝炎患者进展为肝衰竭的独立危险因素。

关键词: 急性戊型肝炎, 临床特征, 肝衰竭, 老年人, 预后

Abstract: Objective To study on the clinical characteristics and prognosis of hepatitis E, and to explore the risk factors for its progression to liver failure. Methods The clinical data of 109 patients with acute hepatitis E were retrospectively analyzed. The patients were divided into an elderly group (n=37) and a non-elderly group (n=72) according to the patients′ age. Based on their comorbidities the patients were classified into an acute hepatitis E group (n=86) and an acute hepatitis E combined with other liver diseases group (n=23). The patients were further categorized into a liver failure group (n=23) and a non-liver failure group (n=86) based on whether they progressed to liver failure. The clinical characteristics, laboratory indicators, and treatment outcomes among the groups were compared. Results Within the 109 patients, 35 cases were cured, 61 cases improved. The peak values of alkaline phosphatase (ALP), total bilirubin (TBiL) and international normalized ratio (INR), the incidences of jaundice and complications of ascites and hepatic encephalopathy, the rate of liver failure, hospital stay duration, and the hospitalization costs of the elderly group were higher than those of the non-elderly group (P<0.05), whereas the levels of TCHOL (total cholesterol) and HDL-C (high-density lipoprotein cholesterol), valley value of Alb (albumin), and the cure rate of the elderly group were lower than those of the non-elderly group (P<0.05). There were no statistically significant differences between the two groups in terms of gender composition, other symptoms, the rates of other complication, the rates of improvement or inefficacy (P>0.05). In the group of patients with hepatitis E combined with other liver diseases, the peak values of TBiL, the peak values of PT (prothrombin time), the peak values of INR, the incidence of symptoms abdominal distension and fatigue, the incidence of complications ascites and hepatic encephalopathy, and the rate of liver failure were all higher than those of the hepatitis E group (P<0.05), whereas the valley value of Alb and the level of low-density lipprotein cholesterol (LDL-C) of patients in the hepatitis E combined with other liver diseases group were lower than those of the hepatitis E group (P<0.05). There were no statistically significant differences between the two groups in terms of gender composition, age distribution, hospital stay duration, hospitalization costs, cure rate, and improvement rate (P>0.05). In the liver failure group, the peak values of alanine aminotransferase (ALT), aspartate aminotransferase (AST), TBiL, PT, activated partial thromboplastin time (APTT), INR, globulin (GLO), and triglyceride (TG), the incidences of symptoms such as jaundice, abdominal distension, fatigue, poor appetite, skin itching and dark urine, the incidences of complications including hypoproteinemia, ascite, hepatic encephalopathy, hospitalization duration, hospitalization costs and improvement rates were all higher than those in the non-liver failure group (P<0.05), whereas the valley value of Alb, TCHOL and HDL-C levels, as well as the cure rate of patients in the liver failure group were lower when compared to those of the non-liver failure group. There were no statistically significant differences between the two groups in terms of gender composition, inefficacy, peak values of ALP, γ-glutamyl transpeptadase (GGT), creatinine (Cr), urea (Ur), and LDL-C (P>0.05). The indicators with statistically significant differences between the two groups were included in binary Logistic regression analysis, and the peak value of INR and TBiL were found to be independent risk factors for liver failure in patients with hepatitis E (P<0.05). Conclusion Elderly patients and those with hepatitis E combined with other liver diseases tend to have more severe conditions, with a higher incidence of ascites, complications such as hepatic encephalopathy, and liver failure. Therefore, it is important to enhance the screening and monitoring of hepatitis E in these two populations. Binary logistic regression analysis found that the peak values of INR and TBiL are independent risk factors for the progression of hepatitis E to liver failure.

Key words: Acute Hepatitis E, Clinical characteristics, Liver failure, Elderly individuals, Prognosis